Peptide Decoy for MARCKS Phosphorylation Attenuation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively enhance memory, particularly in aged individuals, and are inadequate in addressing the neuropathological connections associated with Alzheimer's disease, as they do not adequately target the RhoA/ROCK pathway's downstream target, myristoylated alanine-rich C-kinase substrate (MARCKS).
Innovation Solution
A biologically active peptide comprising a sequence that competes for phosphorylation with MARCKS, specifically utilizing a TAT protein transduction domain and residues surrounding serine phosphorylation targets (Ser159 and Ser163), is administered to mammals to attenuate MARCKS phosphorylation, thereby enhancing memory and promoting neurite outgrowth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If MARCKS is targeted to enhance memory, then memory enhancement is achieved, but the complexity of targeting the specific phosphorylation pathway increases
Solution Approach 1:
The patent uses a peptide decoy as an intermediary molecule that mediates the inhibition of MARCKS phosphorylation. The decoy peptide contains a phosphorylation site that mimics MARCKS, attracting and sequestering PKC to prevent it from phosphorylating MARCKS, thus enhancing memory through this specific pathway without direct intervention in the complex pathway
Solution Approach 2:
The invention creates a simplified copy of the MARCKS phosphorylation site within a peptide decoy structure. This copy contains the essential serine residues that are phosphorylated by PKC in the natural MARCKS pathway, allowing the decoy to replicate the key functional element needed for pathway inhibition without the full complexity of the original protein
2Reliability
If a peptide decoy is used to compete for phosphorylation with MARCKS, then MARCKS phosphorylation is attenuated, but the specificity of targeting serine residues 159 and 163 must be maintained
Solution Approach 1:
The peptide decoy is designed with local quality by incorporating only the specific serine residues (159 and/or 163) and surrounding amino acid sequence from MARCKS that are critical for PKC recognition and phosphorylation. This localized replication of the phosphorylation site ensures high specificity for the intended target while keeping the overall peptide structure simple and manageable
3Productivity
If the TAT protein transduction domain is incorporated into the peptide, then cellular uptake is enhanced, but the peptide length and complexity increase
Solution Approach 1:
The invention merges two distinct functional elements into a single peptide construct: the TAT protein transduction domain for efficient cellular uptake and the MARCKS-derived phosphorylation site sequence for PKC binding and phosphorylation. This combination allows the peptide to simultaneously achieve high cellular penetration and specific pathway inhibition, resolving the contradiction between uptake efficiency and structural simplicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide decoy effectively improves spatial working memory in aged rats by reducing MARCKS phosphorylation, leading to enhanced performance in memory-related tasks and potentially offering therapeutic benefits for memory loss and Alzheimer's disease.
Implementation Method 1
A biologically active peptide comprising a first sequence including SEQ ID NO: 2; and a second sequence selected from SEQ ID NO: 3, wherein the second sequence comprises a first serine residue, wherein the first serine residue is selected from the group comprising serine number 159 and serine number 163
Data Source
AI summary
Compounds derived from a transduction complex that enhance memory in mammals and methods of enhancing memory using said compounds are disclosed.